Literature DB >> 21669398

Viral infection augments Nod1/2 signaling to potentiate lethality associated with secondary bacterial infections.

Yun-Gi Kim1, Jong-Hwan Park, Thornik Reimer, Darren P Baker, Taro Kawai, Himanshu Kumar, Shizuo Akira, Christiane Wobus, Gabriel Núñez.   

Abstract

Secondary bacterial infection is a common sequela to viral infection and is associated with increased lethality and morbidity. However, the underlying mechanisms remain poorly understood. We show that the TLR3/MDA5 agonist poly I:C or viral infection dramatically augments signaling via the NLRs Nod1 and Nod2 and enhances the production of proinflammatory cytokines. Enhanced Nod1 and Nod2 signaling by poly I:C required the TLR3/MDA5 adaptors TRIF and IPS-1 and was mediated by type I IFNs. Mechanistically, poly I:C or IFN-β induced the expression of Nod1, Nod2, and the Nod-signaling adaptor Rip2. Systemic administration of poly I:C or IFN-β or infection with murine norovirus-1 promoted inflammation and lethality in mice superinfected with E. coli, which was independent of bacterial burden but attenuated in the absence of Nod1/Nod2 or Rip2. Thus, crosstalk between type I IFNs and Nod1/Nod2 signaling promotes bacterial recognition, but induces harmful effects in the virally infected host.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21669398      PMCID: PMC3125972          DOI: 10.1016/j.chom.2011.05.006

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  44 in total

1.  Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin.

Authors:  B Beutler; I W Milsark; A C Cerami
Journal:  Science       Date:  1985-08-30       Impact factor: 47.728

2.  A role for IFN-alpha beta in virus infection-induced sensitization to endotoxin.

Authors:  L Doughty; K Nguyen; J Durbin; C Biron
Journal:  J Immunol       Date:  2001-02-15       Impact factor: 5.422

Review 3.  Toll-like receptors in the pathogenesis of human disease.

Authors:  Donald N Cook; David S Pisetsky; David A Schwartz
Journal:  Nat Immunol       Date:  2004-10       Impact factor: 25.606

4.  The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses.

Authors:  Mitsutoshi Yoneyama; Mika Kikuchi; Takashi Natsukawa; Noriaki Shinobu; Tadaatsu Imaizumi; Makoto Miyagishi; Kazunari Taira; Shizuo Akira; Takashi Fujita
Journal:  Nat Immunol       Date:  2004-06-20       Impact factor: 25.606

5.  Endotoxemia in human septic shock.

Authors:  R L Danner; R J Elin; J M Hosseini; R A Wesley; J M Reilly; J E Parillo
Journal:  Chest       Date:  1991-01       Impact factor: 9.410

6.  MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia.

Authors:  J Bernhagen; T Calandra; R A Mitchell; S B Martin; K J Tracey; W Voelter; K R Manogue; A Cerami; R Bucala
Journal:  Nature       Date:  1993-10-21       Impact factor: 49.962

7.  Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome.

Authors:  L C Casey; R A Balk; R C Bone
Journal:  Ann Intern Med       Date:  1993-10-15       Impact factor: 25.391

8.  Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan.

Authors:  Stephen E Girardin; Ivo G Boneca; Leticia A M Carneiro; Aude Antignac; Muguette Jéhanno; Jérôme Viala; Karsten Tedin; Muhamed-Kheir Taha; Agnes Labigne; Ulrich Zähringer; Anthony J Coyle; Peter S DiStefano; John Bertin; Philippe J Sansonetti; Dana J Philpott
Journal:  Science       Date:  2003-06-06       Impact factor: 47.728

Review 9.  How do viral infections predispose patients to bacterial infections?

Authors:  Carol Beadling; Mark K Slifka
Journal:  Curr Opin Infect Dis       Date:  2004-06       Impact factor: 4.915

10.  Evidence for a gamma-interferon receptor that regulates macrophage tumoricidal activity.

Authors:  A Celada; P W Gray; E Rinderknecht; R D Schreiber
Journal:  J Exp Med       Date:  1984-07-01       Impact factor: 14.307

View more
  61 in total

Review 1.  Modulating immunity as a therapy for bacterial infections.

Authors:  Robert E W Hancock; Anastasia Nijnik; Dana J Philpott
Journal:  Nat Rev Microbiol       Date:  2012-03-16       Impact factor: 60.633

2.  Metagenomics and personalized medicine.

Authors:  Herbert W Virgin; John A Todd
Journal:  Cell       Date:  2011-09-30       Impact factor: 41.582

Review 3.  NOD proteins: regulators of inflammation in health and disease.

Authors:  Dana J Philpott; Matthew T Sorbara; Susan J Robertson; Kenneth Croitoru; Stephen E Girardin
Journal:  Nat Rev Immunol       Date:  2013-12-13       Impact factor: 53.106

Review 4.  The Role of Nucleotide-Binding Oligomerization Domain-Like Receptors in Pulmonary Infection.

Authors:  Kristin M Wiese; Bria M Coates; Karen M Ridge
Journal:  Am J Respir Cell Mol Biol       Date:  2017-08       Impact factor: 6.914

5.  Immunology: virus and bacterium gang up on host.

Authors:  Christiaan van Ooij
Journal:  Nat Rev Microbiol       Date:  2011-08-15       Impact factor: 60.633

Review 6.  The virome in host health and disease.

Authors:  Ken Cadwell
Journal:  Immunity       Date:  2015-05-19       Impact factor: 31.745

7.  Commensal microbes and interferon-λ determine persistence of enteric murine norovirus infection.

Authors:  Megan T Baldridge; Timothy J Nice; Broc T McCune; Christine C Yokoyama; Amal Kambal; Michael Wheadon; Michael S Diamond; Yulia Ivanova; Maxim Artyomov; Herbert W Virgin
Journal:  Science       Date:  2014-11-27       Impact factor: 47.728

8.  Critical role for interferon regulatory factor 3 (IRF-3) and IRF-7 in type I interferon-mediated control of murine norovirus replication.

Authors:  Larissa B Thackray; Erning Duan; Helen M Lazear; Amal Kambal; Robert D Schreiber; Michael S Diamond; Herbert W Virgin
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

9.  The Scaffolding Protein IQGAP1 Interacts with NLRC3 and Inhibits Type I IFN Production.

Authors:  Aaron M Tocker; Emily Durocher; Kimberly D Jacob; Kate E Trieschman; Suzanna M Talento; Alma A Rechnitzer; David M Roberts; Beckley K Davis
Journal:  J Immunol       Date:  2017-09-01       Impact factor: 5.422

10.  TLR agonists stimulate Nlrp3-dependent IL-1β production independently of the purinergic P2X7 receptor in dendritic cells and in vivo.

Authors:  Yuan He; Luigi Franchi; Gabriel Núñez
Journal:  J Immunol       Date:  2012-12-07       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.